These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2506109)

  • 21. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
    Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
    Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
    Bradford PA; Jacobus NV; Bhachech N; Bush K
    Antimicrob Agents Chemother; 1996 Jan; 40(1):260-2. PubMed ID: 8787920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime.
    Venkatachalam KV; Huang W; LaRocco M; Palzkill T
    J Biol Chem; 1994 Sep; 269(38):23444-50. PubMed ID: 8089110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1989 May; 50(1-2):97-100. PubMed ID: 2661324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two variants of transferrable extended-spectrum TEM-beta-lactamase successively isolated from a clinical Escherichia coli isolate.
    Vedel G; Mabilat C; Goussard S; Picard B; Fournier G; Gilly L; Paul G; Philippon A
    FEMS Microbiol Lett; 1992 Jun; 72(2):161-6. PubMed ID: 1505739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.
    Poirel L; Naas T; Le Thomas I; Karim A; Bingen E; Nordmann P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3355-61. PubMed ID: 11709308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected enzyme TEM-126: role of mutation Asp179Glu.
    Delmas J; Robin F; Bittar F; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4280-7. PubMed ID: 16189109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.
    Danel F; Hall LM; Livermore DM
    J Antimicrob Chemother; 1999 Mar; 43(3):339-44. PubMed ID: 10223588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes.
    Chanal C; Poupart MC; Sirot D; Labia R; Sirot J; Cluzel R
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1817-20. PubMed ID: 1416873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
    Bonnet R; Dutour C; Sampaio JL; Chanal C; Sirot D; Labia R; De Champs C; Sirot J
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2269-75. PubMed ID: 11451684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.
    Sirot D; Chanal C; Labia R; Meyran M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Oct; 24(4):509-21. PubMed ID: 2693430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family.
    Wu SW; Dornbusch K; Norgren M; Kronvall G
    J Antimicrob Chemother; 1992 Jul; 30(1):3-16. PubMed ID: 1429334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
    Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical characteristics of extended broad spectrum beta-lactamases.
    Bush K; Singer SB
    Infection; 1989; 17(6):429-33. PubMed ID: 2613337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.